| 1 | Study | 2.57% | |
| 2 | Disease | 1.93% | |
| 3 | Patients | 1.93% | |
| 4 | Risk | 1.61% | |
| 5 | Kidney | 0.96% | |
| 6 | Case | 0.96% | |
| 7 | Type | 0.96% | |
| 8 | Chronic | 0.96% | |
| 9 | Could | 0.64% | |
| 10 | Links | 0.64% | |
| 11 | Damage | 0.64% | |
| 12 | Medicine | 0.64% | |
| 13 | Review | 0.64% | |
| 14 | Health | 0.64% | |
| 15 | Systematic | 0.64% | |
| 16 | New | 0.64% | |
| 17 | Alzheimer’s | 0.64% | |
| 18 | Sclerosis | 0.64% | |
| 19 | Rare | 0.64% | |
| 20 | Report | 0.64% | |
| 21 | Efficacy | 0.64% | |
| 22 | Cancer | 0.64% | |
| 23 | According | 0.64% | |
| 24 | Chikungunya | 0.64% | |
| 25 | D.C. | 0.64% | |
| 26 | Semaglutide | 0.64% | |
| 27 | Potential | 0.64% | |
| 28 | Trial | 0.64% | |
| 29 | Encephalitis | 0.64% | |
| 30 | Diabetes | 0.64% | |
| 31 | France | 0.64% | |
| 32 | Cardiovascular | 0.64% | |
| 33 | Clinical | 0.64% | |
| 34 | Mexico | 0.32% | |
| 35 | Candidemia | 0.32% | |
| 36 | Gain | 0.32% | |
| 37 | Loss | 0.32% | |
| 38 | scRNA-Seq | 0.32% | |
| 39 | Longer | 0.32% | |
| 40 | Vaccine | 0.32% | |
| 41 | CKD | 0.32% | |
| 42 | Two | 0.32% | |
| 43 | Lifespan | 0.32% | |
| 44 | Japan | 0.32% | |
| 45 | Trending | 0.32% | |
| 46 | Climate | 0.32% | |
| 47 | Drug | 0.32% | |
| 48 | Healthcare | 0.32% | |
| 49 | Confirms | 0.32% | |
| 50 | Vasospasm | 0.32% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Hindustan Times
2025-06-18 11:51:08
Use of JYNNEOS (Smallpox and Mpox Vaccine, ...
Centers for Disease Control and Prevention | CDC (
2025-06-18 09:22:30
France Confirms Second Locally-Acquired Chikungunya Case in the Mainland - Vax-Before
Travel
2025-06-18 06:03:53
Live Science
2025-06-18 05:21:55
Tirzepatide and Brain Disease; Lamotrigine Warning Challenged; APOE4's Links
MedPage Today
2025-06-18 04:10:49
NeurologyLive
2025-06-18 04:04:46